Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Monoclonal antibody therapies for solid tumors.

Tassev DV, Cheung NK.

Expert Opin Biol Ther. 2009 Mar;9(3):341-53. doi: 10.1517/14712590802715764 . Review.

PMID:
19216623
2.

Approved monoclonal antibodies for cancer therapy.

Boyiadzis M, Foon KA.

Expert Opin Biol Ther. 2008 Aug;8(8):1151-8. doi: 10.1517/14712598.8.8.1151 . Review.

PMID:
18613766
3.

Anticancer antibodies.

Ross JS, Gray K, Gray GS, Worland PJ, Rolfe M.

Am J Clin Pathol. 2003 Apr;119(4):472-85. Review.

4.

Comparing antibody and small-molecule therapies for cancer.

Imai K, Takaoka A.

Nat Rev Cancer. 2006 Sep;6(9):714-27. Review.

PMID:
16929325
5.

Antibody-based therapeutics: focus on prostate cancer.

Ross JS, Gray KE, Webb IJ, Gray GS, Rolfe M, Schenkein DP, Nanus DM, Millowsky MI, Bander NH.

Cancer Metastasis Rev. 2005 Dec;24(4):521-37. Review.

PMID:
16408160
6.

Monoclonal antibodies in the management of solid tumors.

Kalofonos HP, Grivas PD.

Curr Top Med Chem. 2006;6(16):1687-705. Review.

PMID:
17017951
7.

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer management.

Movva S, Verschraegen C.

Expert Opin Biol Ther. 2009 Feb;9(2):231-41. doi: 10.1517/14712590802643347 . Review.

PMID:
19236253
8.

[Monoclonal antibody for cancer treatment].

Achiwa H, Sato S, Ueda R.

Gan To Kagaku Ryoho. 2002 Apr;29(4):495-501. Review. Japanese.

PMID:
11977531
9.

[An overview of antibody therapy against cancer].

Taniguchi H, Imai K.

Nihon Rinsho. 2012 Dec;70(12):2087-92. Review. Japanese.

PMID:
23259378
10.

Antibody-based therapeutics in oncology.

Ross J, Gray K, Schenkein D, Greene B, Gray GS, Shulok J, Worland PJ, Celniker A, Rolfe M.

Expert Rev Anticancer Ther. 2003 Feb;3(1):107-21. Review.

PMID:
12597355
11.

Development trends for monoclonal antibody cancer therapeutics.

Reichert JM, Valge-Archer VE.

Nat Rev Drug Discov. 2007 May;6(5):349-56. Review.

PMID:
17431406
12.

Monoclonal antibody-directed cytotoxic therapy: potential in malignant diseases of aging.

Panousis C, Pietersz GA.

Drugs Aging. 1999 Jul;15(1):1-13. Review.

PMID:
10459728
13.

Development of humanized antibodies as cancer therapeutics.

Qu Z, Griffiths GL, Wegener WA, Chang CH, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM.

Methods. 2005 May;36(1):84-95.

PMID:
15848077
14.
15.

Recombinant antibodies for cancer therapy.

Deonarain MP.

Expert Opin Biol Ther. 2008 Aug;8(8):1123-41. doi: 10.1517/14712598.8.8.1123 . Review.

PMID:
18613764
16.

Antibody therapy of cancer.

Scott AM, Wolchok JD, Old LJ.

Nat Rev Cancer. 2012 Mar 22;12(4):278-87. doi: 10.1038/nrc3236. Review.

PMID:
22437872
17.

Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy.

Krauss J, Arndt MA, Dübel S, Rybak SM.

Curr Pharm Biotechnol. 2008 Jun;9(3):231-4. Review.

PMID:
18673289
18.

Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumors.

Yamamoto N, Yamada Y, Fujiwara Y, Yamada K, Fujisaka Y, Shimizu T, Tamura T.

Jpn J Clin Oncol. 2009 Apr;39(4):260-6. doi: 10.1093/jjco/hyp006. Epub 2009 Mar 4.

19.

Monoclonal antibodies in therapy of solid tumors.

Heimann DM, Weiner LM.

Surg Oncol Clin N Am. 2007 Oct;16(4):775-92, viii. Review.

PMID:
18022544
20.

Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.

Krieg AM.

Oncogene. 2008 Jan 7;27(2):161-7. doi: 10.1038/sj.onc.1210911. Review.

PMID:
18176597
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk